{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:59:46Z","timestamp":1764583186635,"version":"3.46.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98215","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:55:47Z","timestamp":1764582947000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Thrombocytopenia and Type 1 von Willebrand Disease in a Patient With a Femoral Fracture: A Case Report"],"prefix":"10.7759","author":[{"given":"Andr\u00e9","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00348.x","article-title":"Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe","volume":"43","author":"Rosencher N","year":"2003","unstructured":"Rosencher N, Kerkkamp HE, Macheras G, et al.. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003, 43:459-69. 10.1046\/j.1537-2995.2003.00348.x","journal-title":"Transfusion"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02697.x","article-title":"Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study","volume":"50","author":"Vuille-Lessard E","year":"2010","unstructured":"Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study. Transfusion. 2010, 50:2117-24. 10.1111\/j.1537-2995.2010.02697.x","journal-title":"Transfusion"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-015-0188-6","article-title":"Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study","volume":"10","author":"Carling MS","year":"2015","unstructured":"Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015, 10:48. 10.1186\/s13018-015-0188-6","journal-title":"J Orthop Surg Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"Seidizadeh O","year":"2024","unstructured":"Seidizadeh O, Eikenboom JC, Denis CV, et al.. von Willebrand disease. Nat Rev Dis Primers. 2024, 10:51. 10.1038\/s41572-024-00536-8","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek FW","year":"2016","unstructured":"Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016, 375:2067-80. 10.1056\/NEJMra1601561","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James PD","year":"2021","unstructured":"James PD, Connell NT, Ameer B, et al.. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021, 5:280-300. 10.1182\/bloodadvances.2020003265","journal-title":"Blood Adv"},{"key":"ref7","unstructured":"Immune thrombocytopenia. (2023). Accessed. November 21, 2025: https:\/\/www.openanesthesia.org\/keywords\/immune-thrombocytopenia\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari G","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013, 27:495-520. 10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042163","article-title":"Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options","volume":"25","author":"Mititelu A","year":"2024","unstructured":"Mititelu A, Onis\u00e2i MC, Ro\u0219ca A, Vl\u0103d\u0103reanu AM. Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options. Int J Mol Sci. 2024, 25:2163. 10.3390\/ijms25042163","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2019-0014","article-title":"Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease","volume":"57","author":"Onis\u00e2i M","year":"2019","unstructured":"Onis\u00e2i M, Vl\u0103d\u0103reanu AM, Sp\u00eenu A, G\u0103man M, Bumbea H. Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease. Rom J Intern Med. 2019, 57:273-83. 10.2478\/rjim-2019-0014","journal-title":"Rom J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan D","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al.. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019, 3:3780-817. 10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.09.010","article-title":"Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies","volume":"122","author":"Nagrebetsky A","year":"2019","unstructured":"Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP. Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth. 2019, 122:19-31. 10.1016\/j.bja.2018.09.010","journal-title":"Br J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.19224\/ai2019.s119","article-title":"Anaesthesia recommendations for Von Willebrand disease","volume":"60","author":"Bonhomme V","year":"2019","unstructured":"Bonhomme V, Defresne A, Maquoi I, Minon JM. Anaesthesia recommendations for Von Willebrand disease. An\u00e4sthesiol Intensivmed. 2019, 60:119-29. 10.19224\/ai2019.s119","journal-title":"An\u00e4sthesiol Intensivmed"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000065","article-title":"Perioperative management of patients with von Willebrand disease","volume":"2019","author":"O'Donnell JS","year":"2019","unstructured":"O'Donnell JS, Lavin M. Perioperative management of patients with von Willebrand disease. Hematology Am Soc Hematol Educ Program. 2019, 2019:604-9. 10.1182\/hematology.2019000065","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000001273","article-title":"Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience","volume":"35","author":"Toenges R","year":"2024","unstructured":"Toenges R, Miesbach W, Ludwig K, Krammer-Steiner B. Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience. Blood Coagul Fibrinolysis. 2024, 35:49-55. 10.1097\/MBC.0000000000001273","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref16","unstructured":"Statement on ASA physical status classification system. (2020). Accessed. November 13, 2025: https:\/\/www.asahq.org\/standards-and-practice-parameters\/statement-on-asa-physical-status-classification-system."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000521.pub3","article-title":"Anaesthesia for hip fracture surgery in adults","volume":"2","author":"Guay J","year":"2016","unstructured":"Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2016, 2:CD000521. 10.1002\/14651858.CD000521.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1750458918820793","article-title":"Management of von Willebrand disease in patients undergoing total hip and knee arthroplasty","volume":"29","author":"Yaghmour KM","year":"2019","unstructured":"Yaghmour KM, Peng Y, Chisari E, Khan W, McDonnell SM. Management of von Willebrand disease in patients undergoing total hip and knee arthroplasty. J Perioper Pract. 2019, 29:266-9. 10.1177\/1750458918820793","journal-title":"J Perioper Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13962","article-title":"Do patients with von Willebrand disease exhibit higher blood loss and revision rates in hip and knee arthroplasty? A case-control study","volume":"26","author":"Kocao\u011flu H","year":"2020","unstructured":"Kocao\u011flu H, Hennes F, Abdelaziz H, Sandiford NA, Gehrke T, Citak M. Do patients with von Willebrand disease exhibit higher blood loss and revision rates in hip and knee arthroplasty? A case-control study. Haemophilia. 2020, 26:513-9. 10.1111\/hae.13962","journal-title":"Haemophilia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell NT","year":"2021","unstructured":"Connell NT, Flood VH, Brignardello-Petersen R, et al.. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021, 5:301-25. 10.1182\/bloodadvances.2020003264","journal-title":"Blood Adv"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001803","article-title":"Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: second update 2022","volume":"40","author":"Kietaibl S","year":"2023","unstructured":"Kietaibl S, Ahmed A, Afshari A, et al.. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: second update 2022. Eur J Anaesthesiol. 2023, 40:226-304. 10.1097\/EJA.0000000000001803","journal-title":"Eur J Anaesthesiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4829","article-title":"Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety","volume":"349","author":"Poeran J","year":"2014","unstructured":"Poeran J, Rasul R, Suzuki S, et al.. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014, 349:g4829. 10.1136\/bmj.g4829","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2014.05.002","article-title":"The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis","volume":"28","author":"Breau RH","year":"2014","unstructured":"Breau RH, Kokolo MB, Punjani N, et al.. The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis. Transfus Med Rev. 2014, 28:145-55. 10.1016\/j.tmrv.2014.05.002","journal-title":"Transfus Med Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles PS","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A, et al.. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017, 376:136-48. 10.1056\/NEJMoa1606424","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13051","article-title":"Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial","volume":"22","author":"Eghbali A","year":"2016","unstructured":"Eghbali A, Melikof L, Taherahmadi H, Bagheri B. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial. Haemophilia. 2016, 22:e423-6. 10.1111\/hae.13051","journal-title":"Haemophilia"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.005922","article-title":"Preoperative diagnosis and management of inherited bleeding disorders in female adolescents and adults","volume":"66","author":"Wilson RD","year":"2023","unstructured":"Wilson RD. Preoperative diagnosis and management of inherited bleeding disorders in female adolescents and adults. Can J Surg. 2023, 66:E246-63. 10.1503\/cjs.005922","journal-title":"Can J Surg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211064064","article-title":"Prophylactic management of patients with von Willebrand disease","volume":"12","author":"Franchini M","year":"2021","unstructured":"Franchini M, Seidizadeh O, Mannucci PM. Prophylactic management of patients with von Willebrand disease. Ther Adv Hematol. 2021, 12:20406207211064064. 10.1177\/20406207211064064","journal-title":"Ther Adv Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000854","article-title":"Spinal anesthesia in 2 consecutive cesarean deliveries in a parturient with type 3 von Willebrand disease: a case report","volume":"12","author":"Parker JW","year":"2019","unstructured":"Parker JW, James PD, Haley SL. Spinal anesthesia in 2 consecutive cesarean deliveries in a parturient with type 3 von Willebrand disease: a case report. A A Pract. 2019, 12:79-81. 10.1213\/XAA.0000000000000854","journal-title":"A A Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2023-ESRA.104","article-title":"EP042 Spinal anesthesia for C-section in a patient with hemophilia a: case report","volume":"48","author":"Pereira FV","year":"2023","unstructured":"Pereira FV, Homem TR, Guerreiro J, Rocha MT. EP042 Spinal anesthesia for C-section in a patient with hemophilia a: case report. Reg Anesth Pain Med. 2023, 48:A62. 10.1136\/rapm-2023-ESRA.104","journal-title":"Reg Anesth Pain Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40363","article-title":"Anesthetic management including postoperative regional anesthesia in a young adult patient with von Willebrand disease and osteogenesis imperfecta","volume":"15","author":"Rivera-P\u00e9rez D","year":"2023","unstructured":"Rivera-P\u00e9rez D, Rosa-Carrasquillo C, Reyes-Sullivan AJ, Torres-P\u00e9rez H, Crespo MJ. Anesthetic management including postoperative regional anesthesia in a young adult patient with von Willebrand disease and osteogenesis imperfecta. Cureus. 2023, 15:e40363. 10.7759\/cureus.40363","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005355","article-title":"The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia","volume":"132","author":"Bauer ME","year":"2021","unstructured":"Bauer ME, Arendt K, Beilin Y, et al.. The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia. Anesth Analg. 2021, 132:1531-44. 10.1213\/ANE.0000000000005355","journal-title":"Anesth Analg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12359","article-title":"Regional anaesthesia and patients with abnormalities of coagulation","volume":"68","year":"2013","unstructured":"Regional anaesthesia and patients with abnormalities of coagulation. Anaesthesia. 2013, 68.966-72. 10.1111\/anae.12359","journal-title":"Anaesthesia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2018-0041","article-title":"Reducing risk of spinal haematoma from spinal and epidural pain procedures","volume":"18","author":"Breivik H","year":"2018","unstructured":"Breivik H, Norum H, Fenger-Eriksen C, Alahuhta S, Vigf\u00fasson G, Thomas O, Lagerkranser M. Reducing risk of spinal haematoma from spinal and epidural pain procedures. Scand J Pain. 2018, 18:129-50. 10.1515\/sjpain-2018-0041","journal-title":"Scand J Pain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440863-immune-thrombocytopenia-and-type-1-von-willebrand-disease-in-a-patient-with-a-femoral-fracture-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:55:49Z","timestamp":1764582949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440863-immune-thrombocytopenia-and-type-1-von-willebrand-disease-in-a-patient-with-a-femoral-fracture-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.98215","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}